Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership

Business Wire India

Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO).

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/

 

 

 

Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI.

 

“We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around the world.”

 

 

Enbom brings deep experience in cybersecurity and identity security, having built and led global go-to-market organizations across sales and marketing. With a foundation in engineering and a track record of leading cross-functional business initiatives, she brings a 360-degree perspective on the business that enables organizations to scale securely while staying grounded in business outcomes.

 

 

At Yubico, Enbom will lead the company’s global marketing and business development organizations, aligning strategy, leverage sales and execution to accelerate demand and grow revenue. As a core part of its go-to-market strategy, she’ll focus on strengthening executive engagement and advancing Yubico’s leadership in hardware-backed authentication and passwordless adoption: to protect our digital world from AI-Powered Adversary-in-the-Middle Phishing.

 

 

“Yubico built the foundation of modern authentication and continues to play a pivotal role in shaping the future, along with setting the standard for phishing-resistant security and delivering the original passkey,” said Enbom. “What stands out is not only the company’s innovation, but its deep commitment to customers to build open, trusted solutions that scale globally. I’m excited to join this mission-driven team and help more organizations and users to protect digital identities in an increasingly complex threat landscape.

 

 

About Yubico

 

 

Yubico (NASDAQ STOCKHOLM: YUBICO) is a modern cybersecurity company on a mission to make the digital world safer for everyone. As the inventor of the YubiKey, we set the gold standard for modern phishing-resistant, hardware-backed authentication, stopping account takeovers and making secure login simple.

 

 

Since 2007, we’ve helped shape global authentication standards, co-created FIDO2, WebAuthn, and FIDO U2F, and introduced the original passkey. Today, our passkey technology secures people and organizations in over 160 countries—transforming how digital identity is protected from onboarding to account recovery.

 

 

Trusted by the world’s most security-conscious brands, governments, and institutions, YubiKeys work out of the box with hundreds of apps and services, delivering fast, passwordless access without friction or compromise.

 

 

We believe strong security should never be out of reach. Through our philanthropic initiative, Secure it Forward, we donate YubiKeys to nonprofits supporting at-risk communities.

 

 

Headquartered in Stockholm, Sweden; Santa Clara, California; and Singapore, Yubico is proud to be recognized as one of TIME’s 100 Most Influential Companies and Fast Company’s Most Innovative Companies. Learn more at www.yubico.com.

 

 

 

 

 

SK Telecom and DOCOMO Publish White Paper on Requirements for Advancing vRAN and AI‑RAN in Mobile Networks

Seoul, Korea, Mar 31 – SK Telecom (NYSE: SKM, hereinafter referred to as “SKT”) and Japan’s leading mobile operator NTT DOCOMO, INC. today announced the release of a white paper on the key enabling features for vRAN1 evolution and the path to AI-RAN2 (the white paper), as the latest outcome of their ongoing technical cooperation.

The white paper reviews the prospects for further enhancement and advancement of vRAN and AI-RAN – which means intelligent RAN utilizing AI capability – for mobile operators, as well as the associated technical requirements and enabling technologies based on the two companies’ combined experience in mobile network construction and operation. It aims to promote the evolution of vRAN and AI-RAN by encouraging closer collaboration between mobile network operators and equipment vendors in the development of vRAN software.

The white paper analyzes three key technical requirements that are essential to maximizing the benefits of advanced vRAN and AI-RAN.

1.Strict separation of hardware and software to accelerate new feature introduction

By functionally separating RAN software from specific hardware and virtualization platforms, vRAN allows software to be deployed independently from underlying infrastructure, thereby accelerating software‑driven innovation. Such strict separation of hardware and software is identified as a critical factor in the advancement of vRAN and AI‑RAN.

2.Resource pooling for flexible infrastructure and improved resource utilization

In addition to strict hardware-software separation, resource pooling technologies can enable capacity improvements and reductions in power consumption, without compromising service quality, by realizing flexible infrastructure and improving resource utilization. The further development and adoption of this feature could help mobile operators strengthen their competitiveness by supporting more efficient and adaptable network operations.

3.Realization of AI computing capabilities (AI-RAN) by leveraging vRAN systems

Leveraging resource orchestration technologies and an xPU3‑based architecture enables base stations to provide AI computing capabilities without compromising the quality of mobile communication services. This approach aims to evolve vRAN from a mobile communication platform into an integrated AI platform capable of delivering both mobile communication connectivity and AI services.

“This white paper is a meaningful achievement as it presents, from a mobile operator’s perspective, the key features essential for maximizing the benefits of vRAN adoption and for the future evolution toward AI-native networks. We are pleased to have delivered this outcome through our close collaboration with DOCOMO, and we hope it will serve as a catalyst for fostering the broader ecosystem and contribute to the global advancement of next‑generation mobile networks,” said Yu Takki, Head of Network Technology Office at SK Telecom.

“We are pleased that as a result of the technical collaboration with SKT, which began in November 2022, we have jointly published the white paper on the key enabling features for vRAN evolution and the path to AI-RAN. We hope to further strengthen cooperation between the two major mobile operators in East Asia and to share advanced concepts and innovative technologies with the world to realize the 6G era,” said Masafumi Masuda, General Manager of Radio Access Design Department, Senior Vice President, NTT DOCOMO, INC.

DOCOMO and SKT signed a cooperation agreement in November 20224 to advance technology studies of next-generation telecommunications infrastructure for 5G Evolution and 6G. In February 20235, they jointly released two white papers on power-saving technologies for mobile networks and related technologies, as well as 6G requirements. Furthermore, in February 20246, they published a white paper on key considerations for vRAN deployment and operation, focusing on L1 accelerator selection aligned with network design and requirements.

Going forward, DOCOMO and SKT will continue their technical cooperation in various fields, including enhancing the competitiveness and operational efficiency of 5G, as well as international standardization and technology verification towards 6G. Through these efforts, they aim to share their knowledge and innovative technologies with the world and contribute to the further advancement of 5G Evolution and 6G mobile communications.

Read the white paper, “Key Enabling Features for the Evolution of vRAN and the Path to AI-RAN”:https://bit.ly/4sunsGB

1 Technologies that operate mobile base stations as software using general-purpose servers, hardware accelerators, and virtualization platforms.

2 Technologies that integrate AI into the RAN (Radio Access Network) by running AI applications on the RAN infrastructure.

3 A general term for information processing units such as CPU and GPU.

4 SKT Joins Hands with NTT DOCOMO for Comprehensive Cooperation in ICT (November 21, 2022) https://www.sktelecom.com/en/press/pressdetail.do?idx=1549, NTT DOCOMO and SK Telecom to Collaborate on Technological Advancement of Metaverse, Digital Media and 5G/6G (November 22, 2022) https://www.docomo.ne.jp/info/newsrelease/2022/11/2100.html (in Japanese only)

5 SK Telecom and DOCOMO Release White Papers on Green Mobile Networks and 6G Requirements (February 22, 2023) https://www.sktelecom.com/en/press/pressdetail.do?idx=1557&, NTT DOCOMO and SK Telecom Release White Papers on Green Mobile Networks and 6G Requirements (February 22, 2023) https://www.docomo.ne.jp/english/info/mediacenter/pr/2023/022200.html

6 SK Telecom and NTT DOCOMO Release White Paper on Key Considerations for vRAN (February 20, 2024) https://news.sktelecom.com/en/559, NTT DOCOMO and SK Telecom Release White Papers on Base Station Equipment Utilizing Virtualization Technology (February 20, 2024) https://www.docomo.ne.jp/english/info/mediacenter/pr/2024/022000.html

ENTECH confirms commitment to one price and no fuel surcharges

SYDNEY, 31 March 2026 – With so much volatility and uncertainty around the costs of tradeshows particularly around fuel surcharges ENTECH, the only event for AV and entertainment technology professionals that visits every major population centre in Australia and New Zealand, has officially reaffirmed its, “one cost, all in” policy for all its exhibitors and the fact that it will not implement any fuel surcharges for its 2026 roadshows.

ENTECH confirms commitment to one price and no fuel surcharges

ENTECH trucks on tour

ENTECH CEO Kate McKenzie explained, “We’re aware of increasing industry commentary around diesel supply in Australia and understand that some people and companies may have concerns. This is not completely new territory for us as fuel supply volatility is a known operational risk and it is planned for accordingly.”

 

 

ENTECH CEO Kate McKenzie

 

ENTECH’s major logistics contractor operates a fleet of over 100 trucks nationally and works daily within the commercial bulk diesel supply chain.

ENTECH confirms commitment to one price and no fuel surcharges

McKenzie continued, “During previous periods of constraint, supply has consistently been prioritised toward linehaul operations, which is the category we operate in. Our current market view is that supply remains available, with pricing the primary variable. With that in mind we want to be 100% clear on the ENTECH Roadshow position that there will be no fuel surcharge passed on to exhibitors, all logistics and transport commitments remain fully in place and we will absorb any additional fuel costs required to ensure continuity. As always, exhibiting at ENTECH is at one cost, all in.”

ENTECH have built and grown their roadshows on trust, reliability and delivery and as McKenzie states, that does not change under current conditions.

Each year ENTECH moves national exhibitor freight over 10,500 km across Australia and 2,800 km across New Zealand reliably opening each roadshow on time and on budget whilst delivering millions of meaningful interactions between suppliers, manufacturers, practitioners and distributors of professional audio visual and entertainment technology.

When McKenzie states a “one cost, all in” policy for ENTECH exhibitors it’s worth noting that the cost includes all national road freight, on stand catering, marketing through 32 different media channels, the ENTECH-Connect registration and meeting system, pre-show visibility of registered trade, QR badge scanning and data collection, all power requirements, empty case management, on stand tables and chairs, inclusion in interactive demos, inclusion in a Tech Train during each show and all day barista coffee.

Kate McKenzie concluded, “ENTECH is a family business, established with continuous involvement in the industry since 1973. Over that time, we’ve seen the full arc of technological change from valves to solid state, analogue to digital and from heavy magnet loudspeakers to today’s lightweight rare-earth systems alongside the shift from high-cost, tariff-protected markets to globally competitive supply. Throughout all of these changes ENTECH has consistently championed industry capability, workplace standards and professional development that includes the NW Group ENTECH Theatre program. Whilst ENTECH will always move and keep up with the changing times, our ‘one cost, all in’ policy always remains the same.”

Registration for the Australian and New Zealand ENTECH Roadshows is free and open now.

Register today at: www.entech-roadshow.com

 

Giri Trading Reinforces Cultural Commitment with Lamp Donation to Madipakkam Ayyappan Temple

Giri Trading Agency Private Limited has once again strengthened its commitment to preserving India’s spiritual heritage through its “Giri to Society” initiative by donating 4 feet Kuthu Vilakku lamps to Sri Ayyappan Temple, Madipakkam. This meaningful contribution reflects the company’s deep-rooted values and its continuous effort to connect business with cultural responsibility. 

Giri Trading Reinforces Cultural Commitment with Lamp Donation to Madipakkam Ayyappan Temple

 

 
Customer-Driven Contribution
 
What makes this initiative truly special is the strong involvement of customers. A major portion of this contribution has come from the goodwill and voluntary support of customers, showcasing a unique relationship built on trust, faith, and shared cultural values. GIRI has consistently encouraged its customers to be a part of something larger than just a transaction, turning everyday purchases into meaningful contributions towards preserving traditions. This customer-driven model has become a core strength of the “Giri to Society” initiative.
 
Strengthening Cultural and Spiritual Traditions
 
The donation was formally handed over by Giri team members to representatives of Sri Ayyappan Mandali at the temple premises. The presence of the Mandali added spiritual significance to the occasion, as they continue to play an important role in maintaining temple activities and fostering devotion among the local community. The newly donated lamps will support daily rituals and enhance the spiritual atmosphere for devotees visiting the temple.
 
Giri to Society: Ongoing CSR Initiatives
 
Over the years, GIRI has expanded its CSR efforts across multiple temples and cultural platforms. One of its notable contributions includes supporting 21 temples through various initiatives. The company has also been regularly donating 105 kg of pure cow ghee to temples, ensuring that sacred rituals and traditional practices continue without interruption. In addition to this, Giri actively collects and channels donations for cultural activities and festivals, helping communities celebrate traditions in a meaningful and organised way. These efforts highlight the company’s long-term vision of sustaining and promoting India’s rich cultural heritage.
 
Building Relationships Beyond Business
 
Speaking on the occasion, the Management, Mr. Amargirish, Sales Head, stated that GIRI remains committed to strengthening its relationship with customers by involving them in cultural and spiritual initiatives. He emphasised that the “Giri to Society” initiative is not just about donations, but about creating a shared sense of purpose where customers, community, and culture come together. He also noted that such contributions play a vital role in preserving traditions for future generations while keeping the spirit of devotion alive.
 
This Madipakkam temple donation stands as another example of how Giri Trading Agency continues to blend commerce with compassion, building a bridge between customers and culture while making a meaningful impact on society.

Racing Bulls Simulator in Special 2026 Japanese GP Livery Revealed by F1® Authentics

F1® Authentics , operated by Memento Exclusives under licence of Formula 1®, has revealed a brand-new limited edition Official 2026 Team Licensed Simulator for Visa Cash App Racing Bulls Formula One ® Team; exclusively presented in the special ‘Cherry Edition’ livery from the 2026 Japanese Grand Prix.

Created to be synonymous with the vehicles seen on track in Suzuka, the 2026 Japanese Grand Prix livery Motion Simulator has been made by Memento Exclusives’ expert team, featuring engineers and mechanics with decades of experience in motorsport. It utilises Official Team livery data to perfectly replicate the cars of Liam Lawson and Arvid Lindblad, who finished P9 and P14 respectively in Japan, securing more points and maintaining the positive start made to the new season.

Racing Bulls Simulator in Special 2026 Japanese GP Livery Revealed by F1® Authentics

First revealed at Red Bull Tokyo Drift in Shibuya before touring the streets of the city and arriving at the Suzuka Circuit, this unique livery celebrated Sakura, the colourful cherry and almond blossoms seen across Japan in Spring. Designed by Japanese calligrapher Bisen Aoyagi, it features white, red and silver colours and calligraphy, encapsulating a moment in time and the beauty of Japanese culture.

As well as claiming two valuable points in Suzuka, this unique livery has already gained significant popularity amongst the online racing community.  CEO Peter Bayer said the original livery design was part of embracing the cultural context of each race in a meaningful way and the team continues to “look for ways to connect with young fans and the cultures that shape our sport”.

Boasting haptic actuators, a front pivot configuration and haptic rumble feedback, this latest edition Motion Simulator moves authentically to replicate the feeling of every turn from every iconic circuit. These high-tech systems will provide drivers with the most immersive F1® experience possible, beyond winning a seat on the team.

The limited edition Official 2026 Visa Cash App Racing Bulls Formula One ® Team Japanese Grand Prix Motion Simulator is now live on F1Authentics.com.  

Collectors are encouraged to act quickly to become the proud owner of this landmark moment, with this special livery in limited quantities and in high demand.

IMP Nazara Technologies Raises INR 500 Crores through Preferential Issue of Warrants

Mumbai, March 30. Nazara Technologies Limited (BSE: 543280 | NSE: NAZARA), India’s leading diversified gaming and sports media company, today announced a preferential issue of warrants aggregating to INR 500 crores, subject to shareholder and regulatory approvals.

Each warrant is convertible into one equity share and is being issued at a price of INR 260 per share, representing a premium to the current market price, reflecting strong investor confidence in Nazara’s growth strategy.

IMP Nazara Technologies Raises INR 500 Crores through Preferential Issue of Warrants

 

The round includes participation from Riambel Capital PCC, a SEBI-registered Category I Foreign Portfolio Investor, S Gupta Family Investments, Plutus Investment and Holding Private Limited (Promoter Group), Classic Enterprises, and Founders Collective.

The participation from the Promoter Group at the issue price further reinforces alignment and long-term confidence in the Company’s growth strategy.

The proceeds from this fundraise will primarily be used to support strategic acquisitions, including the recently announced Bluetile and BestPlay transaction, and to accelerate growth across the existing business verticals of the Company.

Nitish Mittersain, Jt. MD & CEO, Nazara Technologies said,“This INR 500 crore fundraise comes at an important phase in Nazara’s journey as we execute on our most ambitious growth initiatives, including the Bluetile and BestPlay acquisition. This fresh capital, combined with our acquisition strategy, positions Nazara to build globally scalable, AI-enabled gaming businesses and further strengthen our leadership in the sector.” 

 


BioRestorative Reports Positive Phase 2 Data for BRTX-100 in Chronic Lumbar Disc Disease

BioRestorative Therapies Reports Positive  Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease

MELVILLE, N.Y., March 30, 2026 — BioRestorative Therapies, Inc. (“BioRestorative,” “BRTX,” or the “Company”) (Nasdaq:BRTX), a late-stage clinical regenerative medicine company focused on stem cell-based therapies and products, today announced blinded data from its Phase 2 clinical trial evaluating hypoxic-cultured mesenchymal stem cells for the treatment of chronic lumbar disc disease, with 50% or more of treated patients reporting improvements >50% across key pain and functional outcome measures and no adverse events related to dose-limiting toxicities.  Importantly, the Phase 2 study efficacy endpoint is a greater than a 30% improvement in both the Visual Analog Scale (VAS) and Oswestry Disability Index (ODI) at 52 weeks, which is the minimum improvement needed to meet clinical efficacy success. Chronic lumbar disc disease is a leading cause of chronic lower back pain and disability, affecting millions of patients globally and representing a significant unmet need for non-surgical regenerative therapies.

These data were presented at the 2026 Orthopaedic Research Society Annual Meeting on March 28, 2026 at the Charlotte Convention Center in Charlotte, North Carolina. The Company delivered these data in a presentation titled, “Late-Stage Phase 2 Clinical Safety and Efficacy Data on Intradiscal Injections of Hypoxic Cultured Mesenchymal Stem Cells: Study Update.”

“These blinded data further support the therapeutic potential of our hypoxic-cultured mesenchymal stem cell technology, with  patients demonstrating meaningful improvements across key pain and functional outcome measures,” said Lance Alstodt, BioRestorative Therapies President, Chief Executive Officer, and Chairman.  “Even with blinded data, this signal provides us with confidence in the ultimate outcome of the study, and optimism moving forward with regard to the ultimate potential for meeting a medical need that has, to date, been inadequately addressed.

“Importantly, the results also continue to reinforce the favorable safety and tolerability profile observed to date. In addition, following our recent Type B meeting with the U.S. Food and Drug Administration, we achieved alignment on key elements of a potential Phase 3 clinical trial for BRTX-100, including primary endpoints, statistical powering assumptions, dosing strategy, and the overall development framework. The agency did not raise safety concerns and confirmed that our CMC framework is appropriate for late-stage development.

“Taken together, these developments position the Company to transition from clinical evaluation toward registrational planning. As we move toward the planned unblinding of the Phase 2 study, we have begun preparing for the next stage of clinical development, including protocol planning and other Phase 3 readiness activities, while continuing to generate additional clinical data that may support the advancement and potential commercialization of BRTX-100,” concluded Mr. Alstodt.

Clinically meaningful improvements in both pain and functional outcomes were observed across multiple validated pain and function measures, including the Visual Analog Scale (“VAS”), Oswestry Disability Index (“ODI”), Roland-Morris Disability Questionnaire (“RMDQ”), and Functional Rating Index (“FRI”), with responses sustained for up to two years in patients with longer-term follow-up.

On the VAS for pain, 53.57% of patients reported greater than 50% improvement at 26 weeks (n=28), with the percentage of patients that reported greater than 50% improvement increasing to 75% at 52 weeks (n=12) and remaining 75% at 104 weeks (n=4).

Similar improvements were observed on the ODI, a widely used measure of functional impairment associated with spinal disorders.  Blinded results from the abstract showed 53.57% of patients achieved greater than 50% improvement at 26 weeks (n=28), increasing to 74.63% of patients at 52 weeks (n=12), with 50% of patients maintaining that level of improvement at 104 weeks (n=4).

Improvements were also observed on the RMDQ, with 57.14% of patients experiencing greater than 50% improvement at 26 weeks (n=28), 50% of patients at 52 weeks (n=12), and 75% of patients at 104 weeks (n=4).

FRI demonstrated continued improvement over time, with 35.71% of patients achieving greater than 50% improvement at 26 weeks (n=28), increasing to 66.67% of patients at 52 weeks (n=12) and 50% of patients at 104 weeks (n=4).

Finally, at 26 weeks (n=28) 41% of patients reported a 50% improvement in both ODI and VAS, 55% of patients achieved a 50% improvement in both ODI and VAS at 52 weeks (n=12), and at 104 weeks (n=4) 57% of patients met a 50% improvement in both ODI and VAS.

Tezos RWA Ecosystem Expands with Launch of Metals.io

London, UK—30th March, 2026— Metals.io, a new application for investing in and trading tokenized commodities, is live in the Tezos ecosystem. Developed by a team at Trilitech, a London-based Tezos R&D hub, the web app unlocks access to a selection of rare-earth metals, as well as base metals and minerals that are critical to the technology sector and the AI boom. Designed from the ground up as a single entry-point to a range of tokenized assets, metals.io launches with a dedicated and user-centric web app, which enables users to search for and add a range of tokenized commodities to their portfolios. Metals.io benefits from Tezos’ smart-rollup technology, which boasts sub-50ms latency, meaning that traders on the platform enjoy near-instant transaction confirmations, giving them the critical advantage they need in this dynamic market. 

Tezos RWA Ecosystem Expands with Launch of Metals.io

Metals.io is launching at a pivotal moment, as demand for critical minerals and precious metals has intensified recently, driven on one hand by industrial applications and on the other by investors seeking portfolio diversification options in the face of economic uncertainty. The U.S. government’s establishment of a U.S. critical mineral reserve has led to further attention on these assets, which are essential to modern manufacturing and used in everything from smartphones to wind turbines and fighter jets. Metals.io launches with a number of these tokenized assets already live, with more to be added in the coming months. From today, visitors to the site can access xU3O8 tokenized uranium; VNX Gold (VNXAU), digital proof of ownership of allocated gold which is physically held in a high-security vault in Liechtenstein; and the RARE token from Noemon Tech, which provides transparent exposure to a diversified basket of five strategic metals selected for their critical industrial and technological value. 

“The current rapid pace of innovation in the AI sector and several other related fields is having a knock-on effect on demand for metals and materials that are critical to these endeavors. RARE enables users to gain digital ownership of a diversified basket of strategic metals – including elements such as hafnium, rhenium, indium, neodymium oxide, and praseodymium oxide – all of which are key to modern technologies and industrial applications. The team at Trilitech has developed an incredible gateway for accessing these assets, and Metals.io is a great showcase of how the future of RWA investing is taking place on Tezos,” said Dimitrios Kavvathas, Founder of Noemon Tech Ltd.

Metals.io uses the same underpinning technology as the uranium.io platform that launched on Etherlink, the EVM interface for Tezos, in December 2024. Uranium.io was purpose-built to minimise barriers to investing in uranium ore concentrate (U3O8), the asset that is used in nuclear reactors and could be key to powering the AI revolution. Since launching, uranium.io has played a pivotal role in bridging the multi-billion-dollar traditional commodity market with the speed and transparency of decentralized finance (DeFi), welcoming new investors who would not previously have had the opportunity to own and trade the commodity. The platform has received widespread industry recognition for these innovations, including winning the Best New Product award in the Innovation in Crypto & Web3 category at the latest Benzinga Global Fintech Awards. Now, metals.io is leveraging this successful model to facilitate access to other in-demand assets such as gold and other critical base metals.

“Throughout the 21st century, gold has consistently proven itself as one of the world’s premier assets, delivering stability and preserving wealth when traditional markets waver. VNX Gold (VNXAU) brings this enduring value into the modern era by offering digital tokens that represent verifiable proof of ownership of allocated gold, held in high-security vaults. By combining the strength of industry-leading custodians with the transparency and immutability of blockchain technology, we provide investors with all the security of physical gold, elevated with the efficiency, divisibility, and flexibility of a digital asset, allowing gold to become a fractional and programmable asset that can participate in modern on-chain financial services. Built on the robust and energy-efficient Tezos blockchain, VNX Gold (VNXAU) is making verifiable gold ownership accessible to a new generation of investors,” said Alexander Tkachenko, CEO and Founder, VNX.

Commenting on the launch of Metals.io, Arthur Breitman, co-founder of Tezos, said, “Commodity markets are global and indispensable, yet access to them remains fragmented and layered with intermediaries. As the AI revolution accelerates, energy and critical materials are becoming core economic constraints. Tokenization streamlines ownership and transfer of these assets at a global scale. Metals.io represents the maturation of that model, bringing essential commodities directly onto modern digital rails.”

Cured Nutrition Expands Best-selling Dream Gummies Line With New Strawberry Flavor

The latest addition to CURED’s sleep and stress relief lineup arrives on the heels of a sellout launch.

 

BOULDER, CO (March 30, 2026) – CURED Nutrition, a health and wellness brand harnessing the power of microdosed cannabinoids and functional mushrooms, today announced the launch of a strawberry flavor of its best-selling Dream Gummies. The new flavor is available now at curednutrition.com alongside the original grape.

Dream Gummies rank among CURED’s top-selling products — and for good reason. When the line debuted in November 2025, it sold out within two weeks, signaling a growing consumer demand for credible, third-party tested sleep support. In a 1,000-person study, participants who used CURED products for seven days reported significantly reduced stress and increased feelings of calm and physical ease — making the transition to restful sleep measurably simpler.

“Sleep is the foundation of overall health, and our 235,000+ customers trust us to support their end-of-day unwind in a clean, sustainable way. Dream was built to honor that trust,” said Joseph Sheehey, CEO and Co-Founder of CURED Nutrition.

Dream Gummies combine a precision cannabinoid and botanical formula — CBD, CBN, and a microdose of THC, paired with valerian root, passionflower, and chamomile. The result is deep, restorative sleep without the intoxicating effects of high-dose THC or the next-day fog common to most sleep supplements.

“Dream gummies are the perfect combo of my go-to plants for helping me fall asleep,” said Heather K., a verified user of CURED’s Dream gummies and a CURED Nutrition influencer. “Perimenopause is no joke when it comes to a good night’s sleep, and these gummies are exactly the potency I was hoping for to help my body sleep deep!” 

You can see more of Heather’s reviews of CURED’s products on her Instagram profile, linked here: https://www.instagram.com/cleanerliving.heatherk/?hl=en

CURED’s microdose approach uses approximately one-tenth the THC found in a standard edible — enough to deliver subtle, functional benefits like reduced stress, elevated mood, and improved quality of life, without the high. Every batch is produced in the United States and third-party tested for purity and potency.

HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)

Business Wire India

HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies.

 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/

 

 

HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics

HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics

 

WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate the safety of the Edison® Histotripsy System for the treatment of symptomatic benign prostatic hyperplasia (BPH). The trial is expected to enroll and treat up to 20 patients. Following treatment, participants will undergo imaging within 72 hours of the procedure to assess the immediate treatment effect. Patients will then be followed longitudinally to further evaluate safety and procedural outcomes.

 

“BPH affects millions of men worldwide and most of the existing treatment options require invasive procedures or lengthy recovery times,” said Mike Blue, Chairman and CEO, HistoSonics. “We believe histotripsy’s ability to mechanically destroy targeted tissue, completely non-invasively, has the potential to transform how BPH is treated. In addition, this milestone represents significant progress in our pursuit to expand the unique benefits of histotripsy over a significant number of serious clinical conditions throughout the body.”

 

 

“We are excited and extremely proud that Prince of Wales Hospital is the first center in the world to offer this novel treatment approach in a clinical trial and potentially benefit patients with BPH in the future,” said Dr. Peter Chiu, study investigator and Associate Professor of The Chinese University of Hong Kong. “If shown to be safe and effective, the non-invasive nature of histotripsy has the potential to change how BPH is treated for many patients suffering from lower urinary tract symptoms around the world.”

 

 

Benign prostatic hyperplasia is one of the most common urological conditions affecting aging men. Approximately 50 percent of men over the age of 50 and up to 80 percent of men over the age of 80 experience symptoms associated with BPH. Globally, more than 110 million men are affected by the condition, and its prevalence is expected to continue increasing as populations age.

 

 

The Edison Histotripsy System is currently cleared in the United States for the destruction of liver tumors. The use of the Edison System for the treatment of benign prostatic hyperplasia is currently limited to investigational use.

 

 

About HistoSonics

 

 

HistoSonics is a privately held medical device company developing a non-invasive platform and proprietary sonic beam therapy utilizing the science of histotripsy, a novel mechanism of action that uses focused ultrasound to mechanically destroy and liquefy unwanted tissue and tumors. The company is currently focused on commercializing their Edison System in the US and select global markets for liver treatment while expanding histotripsy applications into other organs like kidney, pancreas, prostate, and others. HistoSonics has offices in Ann Arbor, MI and Minneapolis, MN. For more information on the Edison Histotripsy System please visit: www.histosonics.com. For patient-related information please visit: www.myhistotripsy.com.